Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wolfgang Jaeger is active.

Publication


Featured researches published by Wolfgang Jaeger.


European Urology Supplements | 2015

63 Erythropoietin accelerates the regeneration of ureteral function in a murine model of obstructive uropathy

Claudia Janssen; Wolfgang Jaeger; I. Moskalev; L. Fazli; Joachim W. Thüroff; D. Lange

Purpose: Unilateral ureteral obstruction halts ureteral peristalsis, and may cause pain and lead to infection. Ureteral ability to recover after obstruction removal remains unclear. Erythropoietin has protective effects in nonhematopoietic organs and restores peristalsis in hypocontractile intestinal smooth muscle cells. We investigated the role of erythropoietin in ureteral smooth muscle function and its therapeutic value for unilateral ureteral obstruction. Materials and Methods: Unilateral ureteral obstruction was created for 24, 48 and 72 hours in 22 mice per group using a nontraumatic microclip via laparotomy. We determined erythropoietin, erythropoietin receptor and b-common receptor expression in obstructed and unobstructed ureters by reverse transcriptasepolymerase chain reaction and immunohistochemistry. Ten mice per group received 20 IU erythropoietin for 4 days and controls received saline. Hydronephrosis regression after obstruction removal was assessed by ultrasound. Peristalsis was determined microscopically before and after obstruction removal. Results: Erythropoietin, erythropoietin receptor and b-common receptor were expressed in the unobstructed and obstructed ureters of untreated mice. Erythropoietin mRNA was up-regulated in response to obstruction and erythropoietin expression was identified in ureteral smooth muscle. After obstruction removal hydronephrosis and ureteral dysfunction correlated with obstruction duration. Hydronephrosis resolution and ureteral peristalsis restoration were significantly accelerated in erythropoietin treated mice compared to controls. Conclusions: Erythropoietin treatment significantly promoted functional recovery of the ureter after obstruction removal. Erythropoietin may be a helpful strategy for ureteral motility recovery and hydronephrosis resolution in ureteral obstruction.


European Urology Supplements | 2013

50 Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer

Wolfgang Jaeger; Tetsutaro Hayashi; S. Awrey; Kilian M. Gust; Thomas Cordonnier; Na Li; Ralph Buttyan; T.H. van der Kwast; B. Van Rhijn; J.W. Thüroff; Peter C. Black

INTRODUCTION AND OBJECTIVES: Beside its regulatory functions during development, the Notch pathway plays an eminent role in the tumorigenesis of malignancies. There are four different Notch receptors, which demonstrate context-dependent activity and can work antagonistically to each other. We have previously described a role for Notch-2 in promoting EMT and invasion in bladder cancer (BCA). Our objective here was to elucidate the role of Notch-1 and -3 in EMT and invasion, hypothesizing that both promote the epithelial, less invasive phenotype. METHODS: Immunohistochemistry was performed on a tissue microarray (TMA) of 104 tumors from patients with muscle invasive BCA. Notch-1 and -3 expression was assessed in a panel of bladder cancer cell lines by Western blot (WB) and correlated to previously established EMT status (based on E-cadherin and ZEB1) and invasive ability. Notch-1 and -3 were silenced by lentiviral shRNA vector in 3 cell lines with high constitutive Notch-1 and -3 expression (UM-UC1, UMUC6 and UM-UC15). Protein and mRNA expression of genes relevant to EMT, invasion and stemness were profiled by WB, real-time PCR, immunofluorescence and FACS. Proliferation, migration and invasion were measured by crystal violet, scratch, and Boyden chamber assays, respectively. Self-renewal potential was assessed by clonogenic assay and spheroid formation in MammoCultTM medium. RESULTS: High expression of Notch-3 receptor was associated with lower pathological stage (p 0.05) and absence of lymphovascular invasion (p 0.05) in the cystectomy specimens. Notch-1 expression did not correlate with pathologic variables. WB revealed expression of Notch-1 and -3 in epithelial bladder cancer cell lines only. Silencing of Notch-1 or Notch-3 in the selected epithelial cell lines promoted EMT at the mRNA and protein levels. Accordingly, phenotypic changes were seen in the form of enhanced migration and invasion but unaltered proliferation. In addition, colony and spheroid formation was increased after specific Notch-3 silencing. The simultaneous knock down of Notch-1 and -3 showed no additive effect. CONCLUSIONS: Our results provide evidence that Notch-1 and Notch-3 are involved in invasion and progression of BCA by maintaining an epithelial phenotype and inhibiting EMT and self-renewal potential. This is the opposite of what we have seen previously with Notch-2. Beside verification of our observations in metastatic xenograft models, further investigation is needed to elucidate the molecular mechanisms of these alterations.


Cancer Research | 2013

Abstract 1494: Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer.

Wolfgang Jaeger; Tetsutaro Hayashi; S. Awrey; Kilian M. Gust; Thomas Cordonnier; Na Li; Ralph Buttyan; Estelle Li; Ladan Fazli; Theodorus van der Kwast; Bas W.G. van Rhijn; Peter C. Black

Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background: Beside its regulatory functions during development, the Notch pathway plays an eminent role in the tumorigenesis of malignancies. There are four different Notch receptors, which demonstrate context-dependent activity and can work antagonistically to each other. We have previously described a role for Notch-2 in promoting EMT and invasion in bladder cancer (BCA). Our objective here was to elucidate the role of Notch-1 and -3 in EMT and invasion, hypothesizing that both promote the epithelial, less invasive phenotype. Methods: Immunohistochemistry was performed on a tissue microarray (TMA) of 104 tumors from patients with muscle invasive BCA. Notch-1 and -3 expression was assessed in a panel of bladder cancer cell lines by Western blot (WB) and correlated to previously established EMT status (based on E-cadherin and ZEB1) and invasive ability. Notch-1 and -3 were silenced by lentiviral shRNA vector in 3 cell lines with high constitutive Notch-1 and -3 expression (UM-UC1, UM-UC6 and UM-UC15). Protein and mRNA expression of genes relevant to EMT, invasion and stemness were profiled by WB, real-time PCR, immunofluorescence and FACS. Proliferation, migration and invasion were measured by crystal violet, scratch, and Boyden chamber assays, respectively. Self-renewal potential was assessed by clonogenic assay and spheroid formation in MammoCult™ medium. Results: High expression of Notch-3 receptor was associated with lower pathological stage (p<0.05) and absence of lymphovascular invasion (p<0.05) in the cystectomy specimens. Notch-1 expression did not correlate with pathologic variables. WB revealed expression of Notch-1 and -3 in epithelial bladder cancer cell lines only. Silencing of Notch-1 or Notch-3 in the selected epithelial cell lines promoted EMT at the mRNA and protein levels. Accordingly, phenotypic changes were seen in the form of enhanced migration and invasion but unaltered proliferation. In addition, colony and spheroid formation was increased after specific Notch-3 silencing. The simultaneous knock down of Notch-1 and -3 showed no additive effect. Conclusion: Our results provide evidence that Notch-1 and Notch-3 are involved in invasion and progression of BCA by maintaining an epithelial phenotype and inhibiting EMT and self-renewal potential. This is the opposite of what we have seen previously with Notch-2. Beside verification of our observations in metastatic xenograft models, further investigation is needed to elucidate the molecular mechanisms of these alterations. Citation Format: Wolfgang Jaeger, Tetsutaro Hayashi, Shannon Awrey, Kilian Gust, Thomas Cordonnier, Na Li, Ralph Buttyan, Estelle Li, Ladan Fazli, Theodorus Van Der Kwast, Bas W. G. Van Rhijn, Peter C. Black. Silencing Notch-1 and Notch-3 promotes epithelial-to-mesenchymal transition (EMT) and self-renewal potential in human bladder cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1494. doi:10.1158/1538-7445.AM2013-1494


The Journal of Urology | 2014

MP28-14 TARGETING HER2 WITH TRASTUZUMAB-DM1 (T-DM1) IN HER2-OVEREXPRESSING BLADDER CANCER

Tetsutaro Hayashi; Wolfgang Jaeger; Igor Moskalev; Shannon Awrey; Na Li; Ladan Fazli; Wataru Yasui; Akio Matsubara; Peter McL. Black


Journal of Clinical Oncology | 2014

NOTCH2 inhibition on tumor growth and metastasis in bladder cancer.

Tetsutaro Hayashi; Kilian M. Gust; Wolfgang Jaeger; Shannon Awrey; Na Li; Manuel Altamirano-Dimas; Ralph Buttyan; Ladan Fazli; Akio Matsubara; Peter C. Black


The Journal of Urology | 2013

594 SPECIFIC INHIBITON OF NOTCH-2 AS A NOVEL THERAPY FOR INVASIVE BLADDER CANCER

Tetsutaro Hayashi; Kilian M. Gust; Wolfgang Jaeger; Shannon Awrey; Na Li; Manuel Altamirano-Dimas; Ralph Buttyan; Estelle Li; Ladan Fazli; Peter C. Black


European Urology Supplements | 2017

Organ confined renal cell carcinoma - are the current guidelines sufficient?

Sebastian Frees; M.M. Kamal; S. Nestler; S. Bidnur; P. Levien; A. Neisius; Wolfgang Jaeger; C. Thomas; Joachim W. Thüroff; F.C. Roos


The Journal of Urology | 2016

PD38-01 NOTCH2-HEY AXIS PROMOTES TUMOR GROWTH IN BLADDER CANCER THROUGH CELL CYCLE PROGRESSION AND DEDIFFERENTIATION

Tetsutaro Hayashi; Akihiro Goriki; Htoo Zarni Oo; Roland Seiler; Tilman Todenhöfer; Wolfgang Jaeger; Shannon Awrey; Manuel Altamirano-Dimas; Ladan Fazli; Akio Matsubara; Peter McL. Black


The Journal of Urology | 2016

MP75-13 MONITORING CARDIOVASCULAR EVENTS AFTER TUMOR NEPHRECTOMY IN YOUNG PATIENTS COMPRISING A LONG TERM FOLLOW-UP – A SINGLE CENTER, MATCHED PAIR ANALYSIS BETWEEN DONOR NEPHRECTOMY AND RADICAL TUMOUR NEPHRECTOMY

Patrick Michael Felix Levien; Wolfgang Jaeger; Andreas Neisius; Christian Thomas; Mohammed M. Kamal; C. Hampel; Joachim W. Thüroff; Frederik C. Roos


European Urology Supplements | 2016

791 Notch2-HEY axis promotes tumour growth in bladder cancer through cell cycle progression and de-differentiation

Tetsutaro Hayashi; A. Goriki; H.Z. Oo; Roland Seiler; Tilman Todenhöfer; Wolfgang Jaeger; S. Awrey; M. Altamirano-Dimas; Ladan Fazli; A. Matsubara; Peter McL. Black

Collaboration


Dive into the Wolfgang Jaeger's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ladan Fazli

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Peter C. Black

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Shannon Awrey

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Kilian M. Gust

Medical University of Vienna

View shared research outputs
Top Co-Authors

Avatar

Ralph Buttyan

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Peter McL. Black

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Estelle Li

Vancouver Prostate Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge